Adaptação transcultural e propriedades psicométricas do "Compliance Questionnaire Rheumatology" para a língua portuguesa
##plugins.themes.bootstrap3.article.sidebar##
Publicado
Feb 8, 2024
##plugins.themes.bootstrap3.article.main##
Resumo
Objetivo: Realizar a validação de construto e confiabilidade de uma versão em português do Compliance Questionnaire Rheumatology (bCQR). Métodos: Estudo metodológico de adaptação transcultural, que consistiu nos estágios de tradução, síntese, retrotradução, avaliação por comitê multiprofissional e pré-teste em 52 pacientes ambulatoriais com artrite reumatoide (RA). As propriedades psicométricas foram avaliadas por meio da validação estrutural - análises fatoriais exploratória e confirmatória, com uso da técnica Robust Diagonally Weighted Least Squares (RDWLS) – e consistência interna, com uso do alfa de Cronbach. A fidedignidade composta também foi avaliada. Resultados: A análise fatorial identificou uma estrutura unidimensional, com bom ajuste dos dados após análise fatorial confirmatória (x2 não significativo; p=0.788), resultados adequados quando testados em diferentes modelos de ajuste e manutenção dos 19 itens, conforme as cargas. O coeficiente alfa de Cronbach (0,75) e a fidedignidade composta (0,84) indicaram uma forte estrutura fatorial e a confiabilidade do bCQR. Conclusão: Este estudo valida a adaptação transcultural do bCQR, sendo confiável para avaliar a adesão em pacientes com AR, que pode ser útil na pesquisa e prática clínica, como instrumento de triagem ou orientar intervenções educativas.
##plugins.themes.bootstrap3.article.details##
Como Citar
OliveiraB. E., MonteiroM. P., & FontelesM. M. de F. (2024). Adaptação transcultural e propriedades psicométricas do "Compliance Questionnaire Rheumatology" para a língua portuguesa. Revista Eletrônica Acervo Saúde, 24(2), e14033. https://doi.org/10.25248/reas.e14033.2024
Seção
Artigos Originais
Copyright © | Todos os direitos reservados.
A revista detém os direitos autorais exclusivos de publicação deste artigo nos termos da lei 9610/98.
Reprodução parcial
É livre o uso de partes do texto, figuras e questionário do artigo, sendo obrigatória a citação dos autores e revista.
Reprodução total
É expressamente proibida, devendo ser autorizada pela revista.
Referências
1. ALJOHANI R, et al. Saudi cultural adaptation of the "compliance questionnaire of Rheumatology" for Rheumatoid arthritis patients on disease modifying anti-rheumatic drugs (DMARDs). Saudi Pharmaceutical Journal, 2021; 29 (5): 377-383.
2. BACELAR S, et al. Expressões médicas: glossário de dificuldades em terminologia médica. Brasília: Conselho Federal de Medicina, 2018; 412p.
3. BEATON DE, et al. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine, 2000; 25(24): 3186-3191.
4. BRASIL. Política Nacional de Medicamentos. 2001. Disponível em: https://bvsms.saude.gov.br/bvs/publicacoes/politica_medicamentos.pdf Acessado em: 15 de julho de 2021.
5. BRASIL. Protocolo Clínico e Diretrizes Terapêuticas da Artrite Reumatoide e da Artrite Idiopática Juvenil. 2021. Disponível em: https://www.gov.br/conitec/pt-br/midias/protocolos/20211112_portaria_conjunta_16_pcdt_ar.pdf Acessado em: 17 de dezembro de 2021.
6. BRASIL. Resolução n. 466, de 12 de dezembro de 2012. Disponível em: https://conselho.saude.gov.br/resolucoes/2012/Reso466.pdf Acessado em: 11 de dezembro de 2020.
7. BROWN TA. Confirmatory factor analysis for applied research. 2nd ed. New York: Guilford Publications, 2015; 462p.
8. CINAR F, et al. Cross-cultural adaptation, reliability, and validity of the turkish version of the compliance questionnaire on rheumatology in patients with Behçet's disease. Journal of Transcultural Nursing, 2016; 27(5):480-6.
9. CURTIS JR, et al. Adherence and persistence with methotrexate in rheumatoid arthritis: A Systematic Review. The Journal of Rheumatology, 2016; 43 (11):1997-2009.
10. de KLERK E, et al. Development of a questionnaire to investigate patient compliance with antirheumatic drug therapy. Journal of Rheumatology, 1999; 26 (12): 2635-2641.
11. de KLERK E, et al. The Compliance-Questionnaire-Rheumatology compared with electronic medication event monitoring: a validation study. Journal of Rheumatology, 2003; 30 (11): 2469 – 2475.
12. DESCRITORES EM CIÊNCIAS DA SAÚDE: DeCS. São Paulo (SP): BIREME/OPAS/OMS. 2017. Disponível em: https://decs.bvsalud.org/ Acessado em: 13 de maio de 2022.
13. DISTEFANO C e MORGAN GB. A comparison of diagonal weighted least squares robust estimation techniques for ordinal data. Structural Equation Modeling: a multidisciplinary journal, 2014; 21(3): 425-438.
14. GAUD-LISTRAT V, et al. Adherence to and patient's knowledge of self-management of subcutaneous biologic therapy in chronic inflammatory rheumatic diseases: results of a multicentre cross-sectional study. Clinical and Experimental Rheumatology, 2022; 40(5): 928-935.
15. GOSSEC L, et al. Recommendations for the assessment and optimization of adherence to disease-modifying drugs in chronic inflammatory rheumatic diseases: A process based on literature reviews and expert consensus. Joint Bone Spine, 2019; 86 (1):13-19.
16. HUGUES LD, et al. A 5 item version of the Compliance Questionnaire for Rheumatology (CQR5) successfully identifies low adherence to DMARDs. BMC Musculoskeletal Disorders, 2013; 14.
17. JOPLIN S, et al. Medication adherence in patients with rheumatoid arthritis: the effect of patient education, health literacy, and musculoskeletal ultrasound. BioMed Research International, 2015.
18. KWAN YH, et al. Measurement Properties of Existing Patient-Reported Outcome Measures on Medication Adherence: Systematic Review. Journal of Medical Internet Research, 2020; 22 (10): e19179.
19. LAVIELLE M, et al. Methods to improve medication adherence in patients with chronic inflammatory rheumatic diseases: a systematic literature review. Rheumatic and Musculoskeletal Diseases Open, 2018; 4: e000684.
20. LEE JY, et al. Cultural Adaptation of a Compliance Questionnaire for Patients with Rheumatoid Arthritis to a Korean Version. The Korean Journal of Internal Medicine, 2011; 26 (1).
21. LI CH. Confirmatory factor analysis with ordinal data: Comparing robust maximum likelihood and diagonally weighted least squares. Behavior Research Methods, 2016; 48(3): 936-949.
22. LIMA RM e DUARTE KP. Non-steroidal anti-inflammatory (NSAID) and self-medication. Research, Society and Development, 2022; 11(5): e13211527872.
23. MOKKINK LB, et al. The COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) and how to select an outcome measurement instrument. Brazilian Journal of Physical Therapy, 2016; 20(2): 105-113.
24. MOKKINK LB, et al. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Quality of Life Research, 2010; 19(4): 539-549.
25. NAGY G, et al. EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis. Annals of Rheumatic Diseases, 2022; 81(1): 20-33.
26. PASMA A, et al. Does non-adherence to DMARDs influence hospital-related healthcare costs for early arthritis in the first year of treatment? PLoS One, 2017; 12(2): e0171070.
27. PASQUALI, L. Psicometria: teoria dos testes na psicologia e na educação. Rio de Janeiro: Vozes, 2017; 400p.
28. POLIT DF. Getting serious about test-retest reliability: a critique of retest research and some recommendations. Quality of Life Research, 2014; 23(6): 1713-1720.
29. RAYKOV T. Estimation of composite reliability for congeneric measures. Applied Psychological Measurement, 1997; 21(2): 173-184.
30. RITSCHL V, et al. 2020 EULAR points to consider for the prevention, screening, assessment and management of non-adherence to treatment in people with rheumatic and musculoskeletal diseases for use in clinical practice. Annals of Rheumatic Diseases, 2021; 80(6): 707-713.
31. RITSCHL V, et al. Prevention, screening, assessing and managing of non-adherent behaviour in people with rheumatic and musculoskeletal diseases: systematic reviews informing the 2020 EULAR points to consider. Rheumatic and Musculoskeletal Diseases Open, 2020; 6(3): e001432.
32. SALGADO E, et al. Spanish transcultural adaptation and validation of the English version of the compliance questionnaire in rheumatology. Rheumatology International, 2018; 38(3): 467-472.
33. SALT E, et al. Psychometric properties of three medication adherence scales in patients with rheumatoid arthritis. Journal of Nursing Measurement, 2012; 20 (1): 59–72.
34. SILVA GD, et al. Perfil de gastos com o tratamento da artrite reumatoide para pacientes do Sistema Único de Saúde em Minas Gerais, Brasil, de 2008 a 2013. Ciência e Saúde Coletiva, 2018; 23(4): 1241-1253.
35. SMOLEN JS, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Annals of Rheumatic Diseases, 2020; 79(6): 685-699.
36. STREINER DL. Starting at the beginning: an introduction to coefficient alpha and internal consistency. Journal of Personality Assessment, 2003; 80(1): 99-103.
37. VAN DEN BEMT BJF, et al. Medication adherence in patients with rheumatoid arthritis: a critical appraisal of the existing literature. Expert Review of Clinical Immunology, 2012; 8(4): 337-351.
38. VOSHAAR MJ, et al. Patient-centred care in established rheumatoid arthritis. Best Practice and Research Clinical Rheumatology, 2015; 29(4-5): 643-63.
39. WHO. Adherence to long-term therapies: evidence for action. World Health Organization. 2003. Disponível em: https://apps.who.int/iris/handle/10665/42682 Acessado em: 25 de janeiro de 2021.
40. ZENUK C. Clearing up potential misconceptions about the treatment of rheumatoid arthritis and the use of methotrexate in combination therapy. Canadian Pharmacists Journal, 2018; 151(2): 94-97.
2. BACELAR S, et al. Expressões médicas: glossário de dificuldades em terminologia médica. Brasília: Conselho Federal de Medicina, 2018; 412p.
3. BEATON DE, et al. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine, 2000; 25(24): 3186-3191.
4. BRASIL. Política Nacional de Medicamentos. 2001. Disponível em: https://bvsms.saude.gov.br/bvs/publicacoes/politica_medicamentos.pdf Acessado em: 15 de julho de 2021.
5. BRASIL. Protocolo Clínico e Diretrizes Terapêuticas da Artrite Reumatoide e da Artrite Idiopática Juvenil. 2021. Disponível em: https://www.gov.br/conitec/pt-br/midias/protocolos/20211112_portaria_conjunta_16_pcdt_ar.pdf Acessado em: 17 de dezembro de 2021.
6. BRASIL. Resolução n. 466, de 12 de dezembro de 2012. Disponível em: https://conselho.saude.gov.br/resolucoes/2012/Reso466.pdf Acessado em: 11 de dezembro de 2020.
7. BROWN TA. Confirmatory factor analysis for applied research. 2nd ed. New York: Guilford Publications, 2015; 462p.
8. CINAR F, et al. Cross-cultural adaptation, reliability, and validity of the turkish version of the compliance questionnaire on rheumatology in patients with Behçet's disease. Journal of Transcultural Nursing, 2016; 27(5):480-6.
9. CURTIS JR, et al. Adherence and persistence with methotrexate in rheumatoid arthritis: A Systematic Review. The Journal of Rheumatology, 2016; 43 (11):1997-2009.
10. de KLERK E, et al. Development of a questionnaire to investigate patient compliance with antirheumatic drug therapy. Journal of Rheumatology, 1999; 26 (12): 2635-2641.
11. de KLERK E, et al. The Compliance-Questionnaire-Rheumatology compared with electronic medication event monitoring: a validation study. Journal of Rheumatology, 2003; 30 (11): 2469 – 2475.
12. DESCRITORES EM CIÊNCIAS DA SAÚDE: DeCS. São Paulo (SP): BIREME/OPAS/OMS. 2017. Disponível em: https://decs.bvsalud.org/ Acessado em: 13 de maio de 2022.
13. DISTEFANO C e MORGAN GB. A comparison of diagonal weighted least squares robust estimation techniques for ordinal data. Structural Equation Modeling: a multidisciplinary journal, 2014; 21(3): 425-438.
14. GAUD-LISTRAT V, et al. Adherence to and patient's knowledge of self-management of subcutaneous biologic therapy in chronic inflammatory rheumatic diseases: results of a multicentre cross-sectional study. Clinical and Experimental Rheumatology, 2022; 40(5): 928-935.
15. GOSSEC L, et al. Recommendations for the assessment and optimization of adherence to disease-modifying drugs in chronic inflammatory rheumatic diseases: A process based on literature reviews and expert consensus. Joint Bone Spine, 2019; 86 (1):13-19.
16. HUGUES LD, et al. A 5 item version of the Compliance Questionnaire for Rheumatology (CQR5) successfully identifies low adherence to DMARDs. BMC Musculoskeletal Disorders, 2013; 14.
17. JOPLIN S, et al. Medication adherence in patients with rheumatoid arthritis: the effect of patient education, health literacy, and musculoskeletal ultrasound. BioMed Research International, 2015.
18. KWAN YH, et al. Measurement Properties of Existing Patient-Reported Outcome Measures on Medication Adherence: Systematic Review. Journal of Medical Internet Research, 2020; 22 (10): e19179.
19. LAVIELLE M, et al. Methods to improve medication adherence in patients with chronic inflammatory rheumatic diseases: a systematic literature review. Rheumatic and Musculoskeletal Diseases Open, 2018; 4: e000684.
20. LEE JY, et al. Cultural Adaptation of a Compliance Questionnaire for Patients with Rheumatoid Arthritis to a Korean Version. The Korean Journal of Internal Medicine, 2011; 26 (1).
21. LI CH. Confirmatory factor analysis with ordinal data: Comparing robust maximum likelihood and diagonally weighted least squares. Behavior Research Methods, 2016; 48(3): 936-949.
22. LIMA RM e DUARTE KP. Non-steroidal anti-inflammatory (NSAID) and self-medication. Research, Society and Development, 2022; 11(5): e13211527872.
23. MOKKINK LB, et al. The COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) and how to select an outcome measurement instrument. Brazilian Journal of Physical Therapy, 2016; 20(2): 105-113.
24. MOKKINK LB, et al. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Quality of Life Research, 2010; 19(4): 539-549.
25. NAGY G, et al. EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis. Annals of Rheumatic Diseases, 2022; 81(1): 20-33.
26. PASMA A, et al. Does non-adherence to DMARDs influence hospital-related healthcare costs for early arthritis in the first year of treatment? PLoS One, 2017; 12(2): e0171070.
27. PASQUALI, L. Psicometria: teoria dos testes na psicologia e na educação. Rio de Janeiro: Vozes, 2017; 400p.
28. POLIT DF. Getting serious about test-retest reliability: a critique of retest research and some recommendations. Quality of Life Research, 2014; 23(6): 1713-1720.
29. RAYKOV T. Estimation of composite reliability for congeneric measures. Applied Psychological Measurement, 1997; 21(2): 173-184.
30. RITSCHL V, et al. 2020 EULAR points to consider for the prevention, screening, assessment and management of non-adherence to treatment in people with rheumatic and musculoskeletal diseases for use in clinical practice. Annals of Rheumatic Diseases, 2021; 80(6): 707-713.
31. RITSCHL V, et al. Prevention, screening, assessing and managing of non-adherent behaviour in people with rheumatic and musculoskeletal diseases: systematic reviews informing the 2020 EULAR points to consider. Rheumatic and Musculoskeletal Diseases Open, 2020; 6(3): e001432.
32. SALGADO E, et al. Spanish transcultural adaptation and validation of the English version of the compliance questionnaire in rheumatology. Rheumatology International, 2018; 38(3): 467-472.
33. SALT E, et al. Psychometric properties of three medication adherence scales in patients with rheumatoid arthritis. Journal of Nursing Measurement, 2012; 20 (1): 59–72.
34. SILVA GD, et al. Perfil de gastos com o tratamento da artrite reumatoide para pacientes do Sistema Único de Saúde em Minas Gerais, Brasil, de 2008 a 2013. Ciência e Saúde Coletiva, 2018; 23(4): 1241-1253.
35. SMOLEN JS, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Annals of Rheumatic Diseases, 2020; 79(6): 685-699.
36. STREINER DL. Starting at the beginning: an introduction to coefficient alpha and internal consistency. Journal of Personality Assessment, 2003; 80(1): 99-103.
37. VAN DEN BEMT BJF, et al. Medication adherence in patients with rheumatoid arthritis: a critical appraisal of the existing literature. Expert Review of Clinical Immunology, 2012; 8(4): 337-351.
38. VOSHAAR MJ, et al. Patient-centred care in established rheumatoid arthritis. Best Practice and Research Clinical Rheumatology, 2015; 29(4-5): 643-63.
39. WHO. Adherence to long-term therapies: evidence for action. World Health Organization. 2003. Disponível em: https://apps.who.int/iris/handle/10665/42682 Acessado em: 25 de janeiro de 2021.
40. ZENUK C. Clearing up potential misconceptions about the treatment of rheumatoid arthritis and the use of methotrexate in combination therapy. Canadian Pharmacists Journal, 2018; 151(2): 94-97.